NEJM 9 17 2026 Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
NEJM 9 17 2026 Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock
-
ナレーター：
-
著者：
This clinical study investigated whether administering sodium bicarbonate could improve outcomes for intensive care patients suffering from metabolic acidosis and circulatory shock. Researchers conducted a randomized trial to determine if correcting blood acidity would reduce major adverse kidney events or lower the risk of death for those already requiring blood pressure support. The results demonstrated that there was no significant clinical benefit to using this treatment compared to a placebo, as rates of organ failure and mortality remained largely unchanged between the two groups. Ultimately, the text concludes that this common intervention does not effectively prevent renal dysfunction or improve survival in this specific population of critically ill adults.